
Superbugs exhibition. Wikimedia Commons.
GreenWatch Desk
Marking World AMR Awareness Week 2026, WHO, FAO, UNEP, and WOAH urge sustainable funding, strict prescription enforcement, and cleaner farm and wastewater practices to avert millions of preventable deaths.
DHAKA, Nov 19, 2026 — As the world observes World Antimicrobial Resistance (AMR) Awareness Week from November 18 to 24, international health authorities, agricultural experts, and environmental agencies have issued an urgent call for coordinated global action to avert millions of preventable deaths.
With antimicrobial resistance linked to more than 4.7 million deaths globally in 2021, leaders from the Quadripartite organizations—the World Health Organization (WHO), the Food and Agriculture Organization (FAO), the United Nations Environment Programme (UNEP), and the World Organisation for Animal Health (WOAH)—warn that fragmented efforts, weak surveillance, and chronic underfunding continue to undermine the fight against drug-resistant infections.
Speaking ahead of the global awareness week at the sixth Global Media Forum on Antimicrobial Resistance on November 15, health and environmental specialists outlined a comprehensive roadmap centered on the "One Health" approach. This framework recognizes that the health of humans, domestic and wild animals, plants, and the wider environment are closely linked and interdependent. Under the global theme, "One Health, One Action: Prevent AMR Now," experts stressed that safeguarding life-saving medicines requires immediate, measurable interventions across clinics, farms, and waterways.
At the core of the global response is the newly updated Global Action Plan on AMR for 2026–2036, designed to strengthen infection prevention, expand surveillance networks, promote responsible antimicrobial use, and secure sustainable financing. Jean-Pierre Nyemazi, Director of the Antimicrobial Resistance Department at WHO and Director of the Quadripartite Joint Secretariat on AMR, emphasized that while world leaders have committed to reducing deaths associated with bacterial AMR by 10 percent by 2030, achieving this milestone requires moving beyond high-level declarations to grassroots implementation.
"Behind the alarming statistics are real people, families, farmers, and communities whose lives and livelihoods are directly affected by antimicrobial resistance," Nyemazi noted, pointing out that financing gaps and limited intersectoral coordination remain the primary obstacles to containing the crisis.
Strengthening healthcare infrastructure on the ground is equally critical. Kefas Samson, Senior Technical Officer and Lead of Multisectoral Coordination at the WHO AMR Department, highlighted that inadequate diagnostic capacity and limited access to quality-assured antimicrobials fuel the misuse of drugs. When clinicians lack rapid diagnostic tools to determine whether an infection is bacterial or viral, antibiotics are frequently prescribed unnecessarily, accelerating the evolution of resistant pathogens. Ensuring equitable access to accurate diagnostics and appropriate medicines is therefore a foundational step in preserving drug efficacy.
For densely populated nations like Bangladesh, these global warnings reflect an acute, everyday clinical reality. According to the National AMR Surveillance in Bangladesh conducted by the Institute of Epidemiology, Disease Control and Research (IEDCR), multidrug-resistant (MDR) pathogens were identified in 46 percent of all bacterial isolates collected across sentinel sites between July 2024 and June 2025. In hospital intensive care units (ICUs), that figure surged to a staggering 89 percent.
The IEDCR data, covering over 96,400 patients, also revealed that suspected pan-drug-resistant (PDR) bacteria—organisms resistant to nearly all tested antimicrobial agents—were detected in 6 percent of overall cases and 41 percent of ICU patients. Furthermore, the use of WHO-classified "Watch" group antibiotics, which carry a higher potential for resistance, rose to nearly 91 percent in surveillance hospitals, led by broad-spectrum drugs like ceftriaxone and meropenem.
To counter these trends, Bangladesh is implementing its updated National Strategy and Action Plan for Antimicrobial Resistance Containment (2023–2028), supported by an expanding One Health surveillance network spanning human, livestock, aquaculture, and environmental laboratories. On the regulatory front, the government enacted the Drug and Cosmetics Act 2023, enforced by the Directorate General of Drug Administration (DGDA), which strictly prohibits the sale of antibiotics without a registered physician's prescription and introduces heavy fines for unauthorized dispensing. However, public health advocates note that strict enforcement across thousands of retail pharmacies and informal healthcare providers remains an ongoing challenge.
Because antimicrobials are heavily used in food production to treat and prevent disease in livestock and aquaculture, tackling AMR also requires sweeping reforms in the agricultural sector. Junxia Song, Deputy Chief Veterinarian and Chief of the One Health and Disease Control Branch at FAO, warned that global antibiotic consumption in livestock could surge by nearly 30 percent by 2040 if urgent preventive measures are not adopted. However, Song presented an encouraging pathway forward, noting that improved animal health, better livestock management, and preventive veterinary practices could slash agricultural antibiotic use by as much as 57 percent.
Jane Lwoyero, Programme Officer at WOAH, reinforced this point by identifying routine vaccination, improved farm hygiene, and stricter biosecurity measures as essential tools for preventing outbreaks before they occur. In countries like Bangladesh, where commercial poultry and aquaculture rely heavily on antimicrobials for prophylaxis, keeping animals healthy through clean environments and targeted immunization can drastically reduce antibiotic dependence without compromising food security or rural livelihoods.
Often overlooked in public discussions on drug resistance is the role of the natural environment. Antimicrobials consumed by humans and animals are not fully metabolized, meaning active pharmaceutical residues are regularly excreted and discharged into sewage systems, agricultural runoff, and waterways. Aitziber Echeverria, AMR Coordinator in the Chemicals and Health Branch at UNEP, called for stringent environmental protection measures to stop antimicrobial pollution from wastewater treatment plants, pharmaceutical manufacturing sites, and livestock farms. Echeverria stressed that environmental contamination serves as a major reservoir and pathway through which resistant bacteria develop, mutate, and spread back to humans and animals. Integrating hospital effluent treatment and industrial waste disposal regulations into national AMR action plans is therefore indispensable to breaking the cycle of transmission.
Experts at the forum agreed that technical policies and scientific frameworks will only succeed if they are understood and embraced by the public. Shobha Shukla, Chairperson of the Global AMR Media Alliance (GAMA) and host of the global forum, advocated for a people-centered, rights-based, and gender-transformative approach to tackling AMR. She emphasized that inclusive communication and responsible journalism are vital for translating complex scientific data into actionable everyday guidance for patients, pharmacists, and farmers, while simultaneously holding policymakers accountable for their commitments.
To underscore the power of public communication, the global forum recognized 56 journalists and media professionals as Global AMR Media Awardees 2026 for their work in public education and investigative reporting on drug resistance.
This focus on media engagement was echoed across South Asia as World AMR Awareness Week officially launched on November 18. In Lalitpur, Nepal, the WHO Country Office, FAO Nepal, GAMA Nepal, and the Health Journalists Forum Nepal convened more than 40 journalists alongside senior officials from the Ministry of Health and Food Safety (MoHFS) and the Ministry of Agriculture, Forest and Environment (MoAFE).
During the Nepal media interaction, Dr. Kenza Bennani, Team Lead of the Disease Prevention and Control Unit at WHO Nepal, and Dr. Palpasa Kansakar, National Professional Officer for AMR, joined FAO Livestock and One Health Advisor Dr. Surendra Karki to brief reporters on the cross-sectoral burden of drug resistance. Senior Drug Administrator Shivani Khadgi outlined national regulatory efforts to curb over-the-counter antibiotic sales and improve stewardship, while GAMA Nepal Chair Kalpana Acharya highlighted how informed reporting discourages self-medication and promotes public demand for safe food and clean environments. The event concluded with GAMA Nepal honoring five local journalists for excellence in AMR reporting.
As World AMR Awareness Week continues through November 24, health and environmental leaders reiterate that antimicrobials are a finite, shared global resource. Without decisive intervention, routine surgeries, childbirth, and minor infections could once again become life-threatening.
Preventing a post-antibiotic era demands a synchronized effort: governments must fund national action plans and enforce prescription laws; healthcare providers must prioritize diagnostics and antibiotic stewardship; farmers must adopt biosecurity and vaccination; industries must treat pharmaceutical and hospital wastewater; and citizens must stop buying antibiotics over the counter. Through unified One Health action today, Bangladesh and the wider global community can protect the efficacy of life-saving medicines for generations to come.